151 related articles for article (PubMed ID: 14635604)
1. [Usefulness of lymphatic mapping with sub-areolar injection of patent blue dye, in the typification of breast cancer].
Gallegos-Hernández JF; Chávez-García M
Rev Invest Clin; 2003; 55(4):407-11. PubMed ID: 14635604
[TBL] [Abstract][Full Text] [Related]
2. Sentinel lymph node mapping in breast cancer using subareolar injection of blue dye.
Kern KA
J Am Coll Surg; 1999 Dec; 189(6):539-45. PubMed ID: 10589589
[TBL] [Abstract][Full Text] [Related]
3. [lymphatic Mapping and Sentinel Lymph Node Biopsy in patients with Breast Cancer ].
Gallegos-Hernández JF; Chávez-García MA; Nájera I; Ramírez-Ramírez L; Durán-Martínez M
Gac Med Mex; 2003; 139(3):205-8. PubMed ID: 12872412
[TBL] [Abstract][Full Text] [Related]
4. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
5. Concordance of peritumoral technetium 99m colloid and subareolar blue dye injection in breast cancer sentinel lymph node biopsy.
Kargozaran H; Shah M; Li Y; Beckett L; Gandour-Edwards R; Schneider PD; Khatri VP
J Surg Res; 2007 Nov; 143(1):126-9. PubMed ID: 17950081
[TBL] [Abstract][Full Text] [Related]
6. [Interest of periareolar injection for colorimetric detection of sentinel node in breast cancer].
Mignotte H; Treilleux I; Chassagne-Clément C; Bem C; Lopez R; Martin X; Brémond A
Bull Cancer; 2000 Jul; 87(7-8):600-3. PubMed ID: 10969216
[TBL] [Abstract][Full Text] [Related]
7. Intradermal radioisotope is superior to peritumoral blue dye or radioisotope in identifying breast cancer sentinel nodes.
Lin KM; Patel TH; Ray A; Ota M; Jacobs L; Kuvshinoff B; Chung M; Watson M; Ota DM
J Am Coll Surg; 2004 Oct; 199(4):561-6. PubMed ID: 15454139
[TBL] [Abstract][Full Text] [Related]
8. [Sentinel lymphatic node biopsy for breast cancer in practice].
Strnad P; Rob L; Krízová H; Zuntová A; Chod J; Halaska M
Ceska Gynekol; 2005 Jul; 70(4):291-5. PubMed ID: 16128130
[TBL] [Abstract][Full Text] [Related]
9. [Staging surgery with minimal axillary invasion in breast cancer. Value of the sentinel lymph node].
Gallegos Hernández JF
Ginecol Obstet Mex; 2002 Jan; 70():7-10. PubMed ID: 11913050
[TBL] [Abstract][Full Text] [Related]
10. Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy.
Chagpar A; Martin RC; Chao C; Wong SL; Edwards MJ; Tuttle T; McMasters KM
Arch Surg; 2004 Jun; 139(6):614-8; discussion 618-20. PubMed ID: 15197087
[TBL] [Abstract][Full Text] [Related]
11. Concordance between peri-areolar blue dye and peri-incisional radiotracer injections for sentinel node mapping in patients with a history of primary breast cancer excisonal biopsy.
Mehrabibahar M; Azizi S; Jangjoo A; Saremi E; Kakhki VR; Sadeghi R; Chicken DW; Keshtgar M
Acta Chir Belg; 2014; 114(1):31-3. PubMed ID: 24720135
[TBL] [Abstract][Full Text] [Related]
12. Observational study of blue dye-assisted four-node sampling for axillary staging in early breast cancer.
Narui K; Ishikawa T; Kito A; Shimizu D; Chishima T; Momiyama N; Ichikawa Y; Sasaki T; Nozawa A; Inayama Y; Shimada H; Endo I
Eur J Surg Oncol; 2010 Aug; 36(8):731-6. PubMed ID: 20609549
[TBL] [Abstract][Full Text] [Related]
13. Lymphoscintigraphic visualization of internal mammary nodes with subtumoral injection of radiocolloid in patients with breast cancer.
Shimazu K; Tamaki Y; Taguchi T; Motomura K; Inaji H; Koyama H; Kasugai T; Wada A; Noguchi S
Ann Surg; 2003 Mar; 237(3):390-8. PubMed ID: 12616124
[TBL] [Abstract][Full Text] [Related]
14. Double mapping with subareolar blue dye and peritumoral green dye injections decreases the false-negative rate of dye-only sentinel node biopsy for early breast cancer: 2-site injection is more accurate than 1-site injection.
Anan K; Mitsuyama S; Kuga H; Saimura M; Tanabe Y; Suehara N; Matsunaga H; Nishihara K; Abe Y; Iwashita T; Ihara T; Tamae K; Ono M; Toyoshima S
Surgery; 2006 May; 139(5):624-9. PubMed ID: 16701094
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node biopsy in breast cancer: review on various methodological approaches.
Zengel B; Yararbas U; Sirinocak A; Ozkok G; Denecli AG; Postaci H; Uslu A
Tumori; 2013; 99(2):149-53. PubMed ID: 23748806
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node mapping in early-stage breast cancer: technical issues and results with vital blue dye mapping and radioguided surgery.
Canavese G; Gipponi M; Catturich A; Di Somma C; Vecchio C; Rosato F; Percivale P; Moresco L; Nicolò G; Spina B; Villa G; Bianchi P; Badellino F
J Surg Oncol; 2000 May; 74(1):61-8. PubMed ID: 10861612
[TBL] [Abstract][Full Text] [Related]
17. Blue dye injection in the arm in order to conserve the lymphatic drainage of the arm in breast cancer patients requiring an axillary dissection.
Nos C; Lesieur B; Clough KB; Lecuru F
Ann Surg Oncol; 2007 Sep; 14(9):2490-6. PubMed ID: 17549570
[TBL] [Abstract][Full Text] [Related]
18. [Efficiency of lymphatic mapping by intradermal injection of vital blue dye for sentinel node identification in T1-2 N0-1 M0 stage breast cancer patients].
Kokhreidze I; Nemsadze G; Gersamia G; Dzagnidze G; Janjalia M
Georgian Med News; 2005 Apr; (121):7-10. PubMed ID: 15908713
[TBL] [Abstract][Full Text] [Related]
19. Sentinel lymph node detection by intranipple injection of patent blue dye in breast cancer: a preliminary report of a feasibility study.
Zervoudis S; Iatrakis G; Paschopoulos M; Dousias V; Geahchan N; Stefos T; Pechlivani F; Navrozoglou I
Eur J Gynaecol Oncol; 2012; 33(3):304-5. PubMed ID: 22873105
[TBL] [Abstract][Full Text] [Related]
20. Sentinel lymph node biopsy in breast cancer: results of intradermal periareolar tracer injection and follow-up of sentinel lymph node-negative patients.
van Wessem KJ; Meijer WS
Breast; 2004 Aug; 13(4):290-6. PubMed ID: 15325663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
